ストックスクリーナーアプリを入手
0.7303
0.00%
0.00
前日終値:
$0.7303
開ける：
$0.801
24時間の取引高:
10,338
Relative Volume:
0.00
時価総額：
$10.91M
収益：
$15.23M
当期純損益:
$-19.88M
株価収益率:
-0.352
EPS:
-2.0748
ネットキャッシュフロー:
$-28.95M
1週間 パフォーマンス:
-18.77%
1か月 パフォーマンス:
-1.17%
6か月 パフォーマンス:
-63.85%
1年 パフォーマンス:
-68.79%
1日の値動き範囲:
$0.70
$0.801
1週間の範囲:
$0.70
$0.801
52週間の値動き範囲:
$0.257
$3.42
Allurion Technologies Inc Stock (ALUR) Company Profile
Compare ALUR vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ALUR
Allurion Technologies Inc
|
0.7303 | 10.03M | 15.23M | -19.88M | -28.95M | -2.0748 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Allurion Technologies Inc Stock (ALUR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-14 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2024-10-02 | 開始されました | TD Cowen | Buy |
| 2024-09-06 | 開始されました | ROTH MKM | Buy |
| 2024-02-09 | 開始されました | Jefferies | Buy |
Allurion Technologies Inc (ALUR) 最新ニュース
Allurion Technologies (ALUR) Launches Patient Treatment in U.S. Obesity Market - GuruFocus
Allurion Treats First Commercial Patients in the United States, Marking Major Milestone - BioSpace
Allurion Technologies IncSees growing demand from patients discontinuing GLP-1 therapy - marketscreener.com
Allurion Technologies Inc. WT (ALUR-WT) - Minichart
Market Outlook: How correlated is Allurion Technologies Inc Equity Warrant to the S P5002026 Big Picture & Fast Moving Stock Watchlists - baoquankhu1.vn
Pullback Watch: Is Allurion Technologies Inc undervalued by DCF analysisTrade Entry Report & Community Consensus Stock Picks - baoquankhu1.vn
Long term debt to total equity ratio of Allurion Technologies Inc. – OTC:ALUR - TradingView — Track All Markets
Guidance Update: Is Allurion Technologies Inc Equity Warrant being accumulated by smart moneyBull Run & Real-Time Volume Analysis Alerts - baoquankhu1.vn
My Take: Allurion Technologies' NYSE Delisting Threat [4429c0] - Fathom Journal
Aug Shorts: Is Allurion Technologies Inc Equity Warrant a top pick in the sector2026 Stock Rankings & Entry Point Confirmation Alerts - baoquankhu1.vn
Why Is Allurion Technologies Inc. (ALUR) Stock Up Today? - Meyka
ALUR Technical Analysis & Stock Price Forecast - Intellectia AI
Trade Report: Does Allurion Technologies Inc Equity Warrant offer margin of safetyTrade Performance Summary & Stock Market Timing Techniques - baoquankhu1.vn
Aug Spikes: Should I invest in Allurion Technologies Inc Equity Warrant before earningsGlobal Markets & Verified Momentum Stock Watchlist - baoquankhu1.vn
Allurion Technologies, Inc. 2025 Annual Report: Financial Performance, Stock Information, and SEC Filings - Minichart
Allurion Technologies 2025 10-K — Revenue $15.23M, Net Loss $28.76M - TradingView — Track All Markets
Allurion Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
FDA clears Allurion (NYSE: ALUR) obesity balloon as shares move to OTC - Stock Titan
EBITDA margin % of Allurion Technologies Inc. – OTC:ALUR - TradingView
Operating margin % of Allurion Technologies Inc. – OTC:ALUR - TradingView
Institution Moves: What are Allurion Technologies Incs recent SEC filings showing2026 Market Outlook & Weekly Watchlist of Top Performers - baoquankhu1.vn
Tangible book value per share of Allurion Technologies Inc. – OTC:ALUR - TradingView
EBITDA per share of Allurion Technologies Inc. – OTC:ALUR - TradingView
Cash per share of Allurion Technologies Inc. – OTC:ALUR - TradingView
Allurion Technologies Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
CapEx per share of Allurion Technologies Inc. – OTC:ALUR - TradingView
Aug Mood: Whats Allurion Technologies Incs historical returnWeekly Trading Summary & Real-Time Buy Zone Alerts - baoquankhu1.vn
Total debt per share of Allurion Technologies Inc. – OTC:ALUR - TradingView
Net current asset value per share of Allurion Technologies Inc. – OTC:ALUR - TradingView
ALURW (Allurion Technologies) PB Ratio : (As of Mar. 26, 2026) - GuruFocus
Working capital per share of Allurion Technologies Inc. – OTC:ALUR - TradingView
Market Outlook: What is the cash position of Allurion Technologies Inc2026 Valuation Update & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Book value per share of Allurion Technologies Inc. – OTC:ALUR - TradingView
Hedge Fund Bets: Can Allurion Technologies Inc outperform under higher oil prices2026 Gainers & Real-Time Buy Signal Notifications - baoquankhu1.vn
PUBLIC INVESTMENT FUND's Allurion Technologies Inc(ALURW) Holding History - GuruFocus
Aug EndMonth: Is Allurion Technologies Inc stock showing strong momentum2026 Buyback Activity & Consistent Income Trade Ideas - baoquankhu1.vn
Published on: 2026-03-25 05:37:58 - baoquankhu1.vn
What are Allurion Technologies Incs recent SEC filings showingEarnings Risk Report & Weekly Hot Stock Watchlists - baoquankhu1.vn
Volatility Watch: Does Allurion Technologies Inc have pricing powerPortfolio Update Report & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Entry Recap: Can Allurion Technologies Inc. outperform under higher oil prices - baoquankhu1.vn
Weekly Earnings: Is Allurion Technologies Inc Equity Warrant being accumulated by smart money2026 Technical Patterns & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Aug Wrap: Should I invest in Allurion Technologies Inc Equity Warrant before earningsWeekly Profit Report & Safe Capital Preservation Plans - baoquankhu1.vn
ALUR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Allurion appeals NYSE delisting, cites FDA approval in compliance plan - Investing.com Nigeria
Allurion appeals NYSE delisting, cites FDA approval in compliance plan By Investing.com - Investing.com Australia
Allurion Technologies Inc. Earnings and Revenue – OTC:ALURW - TradingView
US Market Recap: What are Allurion Technologies Incs recent SEC filings showingTreasury Yields & Reliable Trade Execution Plans - baoquankhu1.vn
Allurion Technologies Appeals NYSE Delisting, Leverages FDA Approval to Regain Listing Compliance and Launch Gastric Balloon System in U.S. 1 - Minichart
Allurion Advances Plan to Regain Listing Compliance - 01net
Allurion Faces NYSE Delisting, Shifts Trading to OTC - TipRanks
Allurion Technologies Received Notice of Delisting - TradingView
Allurion Technologies Inc (ALUR) 財務データ
収益
当期純利益
現金流量
EPS
0.74%
1.72%
大文字化:
|
ボリューム (24 時間):